Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 7, 2006; 12(5): 703-708
Published online Feb 7, 2006. doi: 10.3748/wjg.v12.i5.703
Published online Feb 7, 2006. doi: 10.3748/wjg.v12.i5.703
Figure 5 Assessment of expression of VEGF by Western blotting.
3×106 cells were treated with STI571 (0.01, 0.1, and 1 μg/mL) for 12 h, and then cells were rinsed with ice-cold PBS and lysed in RIPA buffer as described in “Materials and methods”. Fifty micrograms of protein was applied in each lane. Lane 1: non-treated; lane 2: STI571 0.01 μg/mL; lane 3: STI571 0.1 μg/mL; lane 4: STI571 1 μg/mL.
- Citation: Jin T, Nakatani H, Taguchi T, Nakano T, Okabayashi T, Sugimoto T, Kobayashi M, Araki K. STI571 (Glivec) suppresses the expression of vascular endothelial growth factor in the gastrointestinal stromal tumor cell line, GIST-T1. World J Gastroenterol 2006; 12(5): 703-708
- URL: https://www.wjgnet.com/1007-9327/full/v12/i5/703.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i5.703